According to this research report, the global biopsy devices market is expected to grow at a CAGR of 6.86% by 2021-2027.
Worldwide, there is an increase in the detection of incidences of cancer, breast cancer, prostate cancer and lung cancer, due to an increase in the level of awareness. In addition to rapid technological advancements such as 3D optical biopsies, targeted MRI biopsies and ultrasound guided biopsies are fueling the adoption of biopsy devices. Many countries have programs for the early diagnosis of breast cancer. Therefore, such initiatives will boost the adoption rate of biopsy devices, which will positively impact the growth of the biopsy device industry. According to Renub Research, the global biopsy device market is expected to reach $ 3.5 billion by 2027.
With improved screening and diagnostic techniques, biopsy devices are an integral part of the diagnostic workup for many medical conditions. This is a procedure of surgically removing tissue from an organ to determine the presence or extent of disease, usually cancerous and inflammatory conditions. This diagnostic procedure is performed by interventional radiologists, surgeons and cardiologists. Biopsies can be taken from any organ using specific biopsy devices as a confirmatory test for cancer and celiac disease. According to the World Cancer Report, cancer rates could increase by another 50% to reach 15 million new cases in 2020. As a result, the increasing incidence of cancer cases and the development of biopsy devices are experiencing strong growth.
Request a free copy of the report: https://www.renub.com/request-sample-page.php?gturl=biopsy-devices-market-global-forecast-p.php
Product Based – Needle Biopsy Has Largest Market Share
The biopsy devices market has been segmented into biopsy needles, guide systems, biopsy guns, reagents, and others. Needle biopsy holds the major market share due to the increasing demand for fine aspiration needles and coring needles for the acquisition of soft tissue samples of internal organs, an application such as breasts, prostate and lungs. According to Statista, breast cancer will account for up to 27.7% of all new cancer cases among women in Asia in 2020.
In addition, guide systems, biopsy guns, reagents, and other devices are used in many applications in many healthcare facilities, such as diagnostic centers, hospitals, and others. Advanced healthcare infrastructure and the increasing prevalence of infections have positively impacted the growth of biopsy devices over the predicted period. This is attributed to the growth of the healthcare sector in emerging economies, the increase in direct healthcare spending and the increase in the number of hospitals. According to this research report, the global biopsy devices market is expected to grow at a CAGR of 6.86% by 2027.
Regional Analysis – North America is the largest contributor to Biopsy Devices segment revenue
In addition, North America is the major contributor of revenue in the biopsy device market. This is due to the great availability of trained health professionals, to well-developed infrastructures and to the presence of a majority of key actors. In addition, Asia-Pacific is a promising destination for manufacturers of biopsy devices. Rapidly improving healthcare infrastructure in emerging Asia-Pacific countries, coupled with high unmet patient needs and increasing incidence of breast cancer, is expected to drive demand for biopsy devices. Our research suggests that the global biopsy device market was US $ 2.2 billion in 2020.
Companies undertake strategies, such as product launches as part of technological innovations and partnerships, to make profits in the industry. For example: in 2021, Oprah Winfrey Network OWN YOUR HEALTH announced an exclusive partnership with Hologic’s Project. This partnership will raise awareness of the inequality of healthcare that black American women receive in the areas of breast, cervical and uterine fibroids. It will provide access to education and prevention tools using Hologic’s comprehensive research and resources. In addition, he will also share original content from famous OWN creative visionaries highlighting the authentic stories and voices of black women.
Latest Renub Research Report “Biopsy Devices Market by Product (Biopsy Needles – Fine Suction Needles, Basic Needles, Guidance Systems – Ultrasound Guided, Stereotaxic Guided, Clinically Guided, Biopsy Guns, Reagents and Kits , others (brushes, curettes and punches) etc), application (breast biopsy, lung biopsy, prostate biopsy, others), region (North America, Europe, Asia-Pacific, rest of the world), end user (center of diagnostics, hospitals and others), companies (Becton Dickinson and Company, Cardinal Health. Braun Melsungen AG, Inc, Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.) “
Follow the link for the full report with detailed table of contents and list of figures and tables: https://www.renub.com/biopsy-devices-market-global-forecast-p.php
Product – The Biopsy Devices market has been covered from 5 perspectives:
1. Biopsy needles
o Thin suction needles
o Basic needles
2. Guidance systems
o Ultrasound guided
o Guided stereotaxic
o Clinically guided
3. Biopsy guns
4. Reagents and kits
5. Others (brushes, curettes and punches, etc.)
Application – The Biopsy Devices Market has been covered from 4 perspectives:
1. Breast biopsy
2. Lung biopsy
3. Prostate biopsy
Region – The Biopsy Devices Market has been covered from 4 perspectives:
1. North America
4. Rest of the world
End User – The Biopsy Devices market has been covered from 3 perspectives:
1. Diagnostic center
â¢ Corporate initiatives
â¢ Sales Analysis
1. Becton Dickinson and company
2. Cardinal Health Inc.
3. Braun Melsungen AG, Inc
4. Olympe Society
5. Boston Scientific Society
6. Medtronic plc
7. Hologic, Inc.
Industry related reports:
Retinal Surgery Devices Market: https://bit.ly/39TIO9L
Medical ceramics market: https://bit.ly/3F7OUBS
Chinese dental market: https://bit.ly/3uAvoZR
Sleep Apnea Devices Market: https://bit.ly/3mdWNwV
Knee Replacement Market: https://bit.ly/3BdlmAB
About the company:
Renub Research is a market research and consulting company. We have over 10 years of experience, particularly in international business-to-business research, surveys and advice. We offer a wide range of business research solutions that help businesses make better business decisions. We partner with clients across industries and regions to identify their most exciting opportunities, address their most critical challenges and transform their businesses. Our large customer base includes major players in the fields of health, travel and tourism, food and beverage, energy and energy, information technology, telecommunications and telecommunications. ‘Internet, chemicals, logistics and automotive, consumer and retail goods, building and construction and agriculture. Our clients rely on our market analysis and data to make informed decisions. We are considered to be one of the best knowledge providers. Our insightful analysis helps consultants, bankers and executives make informed and correct decisions.
Our core team is made up of experienced people with diploma, postgraduate and doctorate degrees. degrees in finance, marketing, human resources, biotechnology, medicine, information technology, environmental sciences and many more.
Phone number: +1 678-302-0700 (US) | + 91-120-421-9822 (IND)
Email: [email protected]
The Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research
Roswell, Georgia 30076
Our research helps to make business decisions: on strategy, organization, operations, technology, mergers and acquisitions, etc. We support many leading companies by providing them with insight and insight across a wide range of markets. Our research reports offer a blend of essential information, analysis and forecasting in today’s ultra-competitive markets.
This version was posted on openPR.